SEONGNAM, South Korea (Reuters) - More than five years after South Korea's scientific reputation was shattered by a cloning research scandal, the country has approved stem cell medication in the form of a treatment for heart attack victims for the world's first clinical use... --snip-- SHARES SOAR ON GROUND-BREAKING TREATMENT FCB-Pharmicell specializes in developing stem cell drugs for incurable diseases. Hearticellgram-AMI takes somatic stem cells extracted from the patient's own bone marrow that are then cultured and directly injected into the damaged heart. "Our first goal is to apply them in patients with illnesses that are not curable through conventional...